Authors:
Mathew, P
Valentine, MB
Bowman, LC
Rowe, ST
Nash, MB
Valentine, VA
Cohn, SL
Castleberry, RP
Brodeur, GM
Look, AT
Citation: P. Mathew et al., Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: A pediatric oncology group study, NEOPLASIA, 3(2), 2001, pp. 105-109
Authors:
Omura-Minamisawa, M
Diccianni, MB
Chang, RC
Batova, A
Bridgeman, LJ
Schiff, J
Cohn, SL
London, WB
Yu, AL
Citation: M. Omura-minamisawa et al., p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease, CLIN CANC R, 7(11), 2001, pp. 3481-3490
Authors:
Daniels, JL
Olshan, AF
Teschke, K
Hertz-Picciotto, I
Savitz, DA
Blatt, J
Bondy, ML
Neglia, JP
Pollock, BH
Cohn, SL
Look, AT
Seeger, RC
Castleberry, RP
Citation: Jl. Daniels et al., Residential pesticide exposure and neuroblastoma, EPIDEMIOLOG, 12(1), 2001, pp. 20-27
Citation: Hm. Katzenstein et al., Treatment and outcome of 83 children with intraspinal neuroblastoma: The Pediatric Oncology Group experience, J CL ONCOL, 19(4), 2001, pp. 1047-1055
Authors:
Norris, MD
Gilbert, J
Smith, SA
Marshall, GM
Salwen, H
Cohn, SL
Haber, M
Citation: Md. Norris et al., Expression of the putative tumour suppressor gene, p73, in neuroblastoma and other childhood tumours, MED PED ONC, 36(1), 2001, pp. 48-51
Authors:
Shaw, PH
Cohn, SL
Morgan, ER
Kovarik, P
Haut, PR
Kletzel, M
Murphy, SB
Citation: Ph. Shaw et al., Natural killer cell lymphoma - Report of two pediatric cases, therapeutic options, and review of the literature, CANCER, 91(4), 2001, pp. 642-646
Authors:
Alvarado, CS
London, WB
Look, AT
Brodeur, GM
Altmiller, DH
Thorner, PS
Joshi, VV
Rowe, ST
Nash, MB
Smith, EI
Castleberry, RP
Cohn, SL
Citation: Cs. Alvarado et al., Natural history and biology of Stage A neuroblastoma: A Pediatric OncologyGroup study, J PED H ONC, 22(3), 2000, pp. 197-205
Citation: Sl. Cohn et al., MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN, J CL ONCOL, 18(21), 2000, pp. 3604-3613
Authors:
Gardaneh, M
Gilbert, J
Haber, M
Norris, MD
Cohn, SL
Schmidt, ML
Marshall, GM
Citation: M. Gardaneh et al., Synergy between 5 ' and 3 ' flanking regions of the human tyrosine hydroxylase gene ensures specific, high-level expression in neuroblastoma cells, NEUROSCI L, 292(3), 2000, pp. 147-150
Authors:
Kletzel, M
Meitar, D
El-Youssef, M
Cohn, SL
Citation: M. Kletzel et al., Gastrointestinal relapse of leukemia, mimicking acute graft vs. host disease, following a stem cell transplant, MED PED ONC, 34(4), 2000, pp. 287-289
Authors:
Tang, XX
Evans, AE
Zhao, HQ
Cnaan, A
London, W
Cohn, SL
Brodeur, GM
Ikegaki, N
Citation: Xx. Tang et al., High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas, CLIN CANC R, 5(6), 1999, pp. 1491-1496
Authors:
Katzenstein, HM
Rademaker, AW
Senger, C
Salwen, HR
Nguyen, NN
Thorner, PS
Litsas, L
Cohn, SL
Citation: Hm. Katzenstein et al., Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growthof human neuroblastoma in nude mice inversely correlates with tumor burden, CLIN CANC R, 5(12), 1999, pp. 4273-4278
Authors:
Perel, Y
Conway, J
Kletzel, M
Goldman, J
Weiss, S
Feyler, A
Cohn, SL
Citation: Y. Perel et al., Clinical impact and prognostic value of metaiodobenzylguanidine imaging inchildren with metastatic neuroblastoma, J PED H ONC, 21(1), 1999, pp. 13-18
Authors:
Haber, M
Bordow, SB
Gilbert, J
Madafiglio, J
Kavallaris, M
Marshall, GM
Mechetner, EB
Fruehauf, JP
Tee, L
Cohn, SL
Salwen, H
Schmidt, ML
Norris, MD
Citation: M. Haber et al., Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells, ONCOGENE, 18(17), 1999, pp. 2777-2782